Inhibition of E6-induced Degradation of its Cellular Substrates by Novel Blocking Peptides

Journal of Molecular Biology

Volumn 335, Issue 4, 2004, Pages 971-985

  Grm, Helena Sterlinko ^a   Weber, Malte ^b   Elston, Rob ^b   McIntosh, Pauline ^b   Griffin, Heather ^b   Banks, Lawrence ^a   Doorbar, John ^b  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

HPV E6; MAGUKs; p53; Peptide libraries; Proteasome

Indexed keywords

AMINO ACID DERIVATIVE; BINDING PROTEIN; PEPTIDE LIBRARY; PROTEIN; PROTEIN DLG; PROTEIN E6; PROTEIN MAG1; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALPHA HELIX; ARTICLE; BINDING AFFINITY; CELL FUNCTION; CELL SUBPOPULATION; CONTROLLED STUDY; MOLECULAR BIOLOGY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INDUCTION; PROTEIN ISOLATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0345862285     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2003.10.079     Document Type: Article

References (45)

1. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 184:1991;9-13.
2. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta. 1288:1996;F55-F78.
3. Vousden K. Interactions between papillomavirus proteins and tumor suppressor gene products. Advan. Cancer Res. 64:1994;1-24.
4. Smotkin D., Wettstein F.O. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc. Natl Acad. Sci. USA. 83:1986;4680-4684.
5. Schwarz E., Freese U., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 314:1985;111-114.
6. Banks L., Spence P., Androphy E., Hubbert N., Matlashewski G., Murray A., Crawford L. Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. J. Gen. Virol. 68:1987;1351-1359.
7. Androphy E., Hubbert N., Schiller J., Lowy D. Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J. 6:1987;989-992.
8. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
9. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 75:1993;495-505.
10. Huibregtse J.M., Scheffner M., Howley P.M. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10:1991;4129-4135.
11. Huibregtse J.M., Scheffner M., Howley P.M. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell Biol. 13:1993;4918-4927.
12. Be X., Hong Y., Wei J., Androphy E., Chen J., Baleja D. Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6-AP. Biochemistry. 40:2001;1293-1299.
13. Kühne C., Banks L. E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. J. Biol. Chem. 273:1998;34302-34309.
14. Elston R.C., Napthine S., Doorbar J. The identification of a conserved binding motif within human papillomavirus type 16 E6 binding peptides, E6-AP and E6BP. J. Gen. Virol. 79:1998;371-374.
15. Lee S.S., Glausinger B., Mantovani F., Banks L., Javier R.T. Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J. Virol. 74:2000;9680-9693.
16. Thomas M., Pim D., Banks L. Human papillomavirus E6 protein interactions. McCance D.J. Perspectives in Medical Virology, 8: Human Papilloma Viruses. 2002;71 Elsevier, Amsterdam.
17. Woods D.F., Bryant P.J. The discs-large tumor suppressor gene of Drosophila encodes a guanylate kinase homolog localized at septate junctions. Cell. 66:1991;451-464.
18. Lue R.A., Marfatia S.M., Branton D., Chishti A.H. Cloning and characterization of hdlg: the human homologue of the Drosophila discs large tumor suppressor binds to protein 4.1. Proc. Natl Acad. Sci. USA. 91:1994;9818-9822.
19. Müller B.M., Kistner U., Veh R.W., Cases-Langhoff C., Becker B., Gundelfinger E.D., Garner C.C. Molecular characterization and spatial distribution of SAP97, a novel presynaptic protein homologous to SAP90 and the Drosophila discs-large tumor suppressor protein. J. Neurosci. 15:1995;2354-2366.
20. Gardiol D., Kühne C., Glaunsinger B., Lee S.S., Javier R., Banks L. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene. 18:1999;5487-5496.
21. Gomperts S.N. Clustering membrane proteins: it's all coming together with the PSD-95/SAP90 protein family. Cell. 84:1996;659-662.
22. Craven S.E., Bredt D.S. PDZ proteins organize synaptic signaling pathways. Cell. 93:1998;495-498.
23. Anderson J.M. Cell signalling: MAGUK magic. Curr. Biol. 6:1996;382-384.
24. Bilder D., Li M., Perrimon N. Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science. 289:2000;113-116.
25. Ponting C., Phillips C. DHR domains in syntrophins, neuronal NO synthases and other intracellular proteins. Trends Biochem. Sci. 20:1995;102-103.
26. Saras J., Heldin C. PDZ domains bind carboxy-terminal sequences of target proteins. Trends Biochem. Sci. 21:1996;455-458.
27. Kim S.K. Polarized signaling: basolateral receptor localization in epithelial cells by PDZ-containing proteins. Curr. Opin. Cell Biol. 9:1997;853-859.
28. Kim E., DeMarco S.J., Marfatia S.M., Christi A.H., Sheng M., Strehler E.E. Plasma membrane Ca2+ ATPase isoform 4b binds to membrane-associated guanylate kinase (MAGUK) proteins via their PDZ (PSD-95/Dlg/ZO-1) domains. J. Biol. Chem. 273:1998;1591-1595.
29. Lee S.S., Weiss R.S., Javier R.T. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc. Natl Acad. Sci. USA. 94:1997;6670-6675.
30. Pim D., Thomas M., Javier R., Gardiol D., Banks L. HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene. 19:2000;719-725.
31. Glaunsinger B.A., Lee S.S., Thomas M., Banks L., Javier R. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene. 19:2000;5270-5280.
32. Thomas M., Glaunsinger B., Pim D., Javier R., Banks L. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Oncogene. 20:2001;5431-5439.
33. Thomas M., Laura R., Hepner K., Guccione E., Sawyers C., Lasky L., Banks L. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene. 21:2002;5088-5096.
34. Dobrosotskaya I.Y., Guy R.K., James G.L. MAGI-1, a membrane-associated guanylate kinase with a unique arrangement of protein-protein interaction domains. J. Biol. Chem. 272:1997;31589-31597.
35. Wu X., Hepner K., Castelino-Prabhu S., Do D., Kaye M.B., Yuan X.J., et al. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc. Natl Acad. Sci. USA. 97:2000;4233-4238.
36. Wu Y., Dowbenko D., Spencer S., Laura R., Lee J., Gu Q., Laskey L.A. Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase. J. Biol. Chem. 275:2000;21477-21485.
37. Dobrosotskaya I.Y., James G.L. MAGI-1 interacts with beta-catenin and is associated with cell-cell adhesion structures. Biochem. Biophys. Res. Commun. 270:2000;903-909.
38. Pim D., Thomas M., Banks L. Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins. Oncogene. 21:2002;8140-8148.
39. Crook T., Tidy J.A., Vousden K.H. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell. 67:1991;547-556.
40. Li X., Coffino P. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J. Virol. 70:1996;4509-4516.
41. Nuber U., Schwarz S., Kaiser P., Schneider R., Scheffner M. Cloning of human ubiquitin-conjugating enzymes UbcH6 and UbcH7 (E2-F1) and characterisation of their interaction with E6-AP and RSP5. J. Biol. Chem. 271:1996;2795-2800.
42. Huang L., Kinnucan E., Wang G., Beaudenon S., Howley P.M., Paveltich N.P. Structure of an E6AP-UbcH7 complex: insights into ubiquitnation by the E2-E3 enzyme cascade. Science. 286:1999;1321-1326.
43. Pim D., Storey A., Thomas M., Massimi P., Banks L. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Oncogene. 9:1994;1869-1876.
44. Thomas M., Massimi P., Jenkins J., Banks L. HPV-18 E6 mediated inhibition of p53 DNA binding activity is independent of E6 induced degradation. Oncogene. 10:1995;261-268.
45. Mantovani F., Massimi P., Banks L. Proteasome-mediated regulation of the hDlg tumour suppressor protein. J. Cell Sci. 114:2001;4285-4292.